TD Cowen Reiterates Buy on Boston Scientific, Maintains $56 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 85.7%

Neg 0% Neu 85.7% Pos 0%

TD Cowen analyst Joshua Jennings reiterates Boston Scientific (NYSE:BSX) with a Buy and maintains $56 price target.

Comments

No comments yet. Be the first!